Logo image of WOK

WORK MEDICAL TECHNOLOGY GR-A (WOK) Stock Fundamental Analysis

NASDAQ:WOK - Nasdaq - KYG9767H1092 - Common Stock - Currency: USD

0.4591  +0.01 (+2.14%)

Fundamental Rating

1

Taking everything into account, WOK scores 1 out of 10 in our fundamental rating. WOK was compared to 189 industry peers in the Health Care Equipment & Supplies industry. WOK may be in some trouble as it scores bad on both profitability and health. WOK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year WOK was profitable.
WOK had a negative operating cash flow in the past year.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

WOK has a Return On Assets of 0.31%. This is in the better half of the industry: WOK outperforms 72.49% of its industry peers.
WOK has a better Return On Equity (0.85%) than 73.55% of its industry peers.
WOK's Return On Invested Capital of 1.11% is fine compared to the rest of the industry. WOK outperforms 68.25% of its industry peers.
Industry RankSector Rank
ROA 0.31%
ROE 0.85%
ROIC 1.11%
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

With a decent Profit Margin value of 0.83%, WOK is doing good in the industry, outperforming 73.02% of the companies in the same industry.
With a decent Operating Margin value of 3.04%, WOK is doing good in the industry, outperforming 68.78% of the companies in the same industry.
WOK has a worse Gross Margin (30.54%) than 75.13% of its industry peers.
WOK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WOK is destroying value.
The number of shares outstanding for WOK has been increased compared to 1 year ago.
The debt/assets ratio for WOK is higher compared to a year ago.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 0.87, we must say that WOK is in the distress zone and has some risk of bankruptcy.
WOK's Altman-Z score of 0.87 is in line compared to the rest of the industry. WOK outperforms 50.26% of its industry peers.
WOK has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.01, WOK is doing worse than 75.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACC0.22
WACC5.13%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 1.03 indicates that WOK should not have too much problems paying its short term obligations.
WOK has a Current ratio of 1.03. This is amonst the worse of the industry: WOK underperforms 89.42% of its industry peers.
A Quick Ratio of 0.87 indicates that WOK may have some problems paying its short term obligations.
WOK's Quick ratio of 0.87 is on the low side compared to the rest of the industry. WOK is outperformed by 82.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.87
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

WOK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3670.13%.
WOK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.18%.
WOK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.93% yearly.
EPS 1Y (TTM)-3670.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.96%
Revenue 1Y (TTM)-15.18%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-63.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.91 indicates a quite expensive valuation of WOK.
Based on the Price/Earnings ratio, WOK is valued a bit cheaper than the industry average as 68.78% of the companies are valued more expensively.
WOK is valuated expensively when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.91
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

99.47% of the companies in the same industry are more expensive than WOK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WOK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WORK MEDICAL TECHNOLOGY GR-A

NASDAQ:WOK (5/5/2025, 3:41:05 PM)

0.4591

+0.01 (+2.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.83%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.70M
AnalystsN/A
Price TargetN/A
Short Float %2.6%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 45.91
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB 0.55
EV/EBITDA 0
EPS(TTM)0.01
EY2.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.93
BVpS0.9
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.31%
ROE 0.85%
ROCE 2.57%
ROIC 1.11%
ROICexc 1.43%
ROICexgc 1.49%
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 7.31
Cap/Depr 656.39%
Cap/Sales 68.25%
Interest Coverage 0.76
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.87
Altman-Z 0.87
F-Score3
WACC5.13%
ROIC/WACC0.22
Cap/Depr(3y)251.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)31.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3670.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.18%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-63.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1081.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-806.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.83%
OCF growth 3YN/A
OCF growth 5YN/A